Literature DB >> 34352941

Prevalence of Kratom Use and Co-Occurring Substance Use Disorders in the United States.

Kevin Y Xu1,2, Carrie M Mintz1, Jacob T Borodovsky1,3, Paul E A Glaser4, Laura J Bierut1,5, Richard A Grucza1,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34352941      PMCID： PMC8647372          DOI： 10.4088/PCC.21br02930

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN： 2155-7780


× No keyword cloud information.
  10 in total

1.  Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program.

Authors:  Kirsten Elin Smith; Thomas Lawson
Journal:  Drug Alcohol Depend       Date:  2017-09-20       Impact factor: 4.492

2.  Patterns of Kratom use and health impact in the US-Results from an online survey.

Authors:  Oliver Grundmann
Journal:  Drug Alcohol Depend       Date:  2017-05-10       Impact factor: 4.492

3.  Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic.

Authors:  Albert Garcia-Romeu; David J Cox; Kirsten E Smith; Kelly E Dunn; Roland R Griffiths
Journal:  Drug Alcohol Depend       Date:  2020-02-03       Impact factor: 4.492

4.  Kratom use in the United States: a diverse and complex profile.

Authors:  Oliver Grundmann; Jane K Babin; Jack E Henningfield; Albert Garcia-Romeu; Andrew C Kruegel; Walter C Prozialeck; Robert B Raffa; Darshan Singh; Kirsten E Smith
Journal:  Addiction       Date:  2020-06-30       Impact factor: 6.526

5.  Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross-sectional study.

Authors:  Jonathan Schimmel; Elise Amioka; Karilynn Rockhill; Colleen M Haynes; Joshua C Black; Richard C Dart; Janetta L Iwanicki
Journal:  Addiction       Date:  2020-04-28       Impact factor: 6.526

6.  Notes from the Field: Kratom (Mitragyna speciosa) Exposures Reported to Poison Centers - United States, 2010-2015.

Authors:  Mehruba Anwar; Royal Law; Josh Schier
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-07-29       Impact factor: 17.586

7.  Lyophilized Kratom Tea as a Therapeutic Option for Opioid Dependence.

Authors:  Lisa L Wilson; Hannah M Harris; Shainnel O Eans; Ariana C Brice-Tutt; Thomas J Cirino; Heather M Stacy; Chloe A Simons; Francisco León; Abhisheak Sharma; Edward W Boyer; Bonnie A Avery; Jay P McLaughlin; Christopher R McCurdy
Journal:  Drug Alcohol Depend       Date:  2020-09-22       Impact factor: 4.492

8.  Current perspectives on the impact of Kratom use.

Authors:  Charles Veltri; Oliver Grundmann
Journal:  Subst Abuse Rehabil       Date:  2019-07-01

9.  Kratom policy: The challenge of balancing therapeutic potential with public safety.

Authors:  Walter C Prozialeck; Bonnie A Avery; Edward W Boyer; Oliver Grundmann; Jack E Henningfield; Andrew C Kruegel; Lance R McMahon; Christopher R McCurdy; Marc T Swogger; Charles A Veltri; Darshan Singh
Journal:  Int J Drug Policy       Date:  2019-05-16

10.  Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions.

Authors:  D A Todd; J J Kellogg; E D Wallace; M Khin; L Flores-Bocanegra; R S Tanna; S McIntosh; H A Raja; T N Graf; S E Hemby; M F Paine; N H Oberlies; N B Cech
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379
  10 in total
  1 in total

Review 1.  Health Effects Associated With Kratom (Mitragyna speciosa) and Polysubstance Use: A Narrative Review.

Authors:  Catherine W Striley; Carolin C Hoeflich; Andrew T Viegas; Lindsey A Berkowitz; Emily G Matthews; Leyla P Akin; Chidinma Iheanyi-Okeahialam; Urmeen Mansoor; Christopher R McCurdy
Journal:  Subst Abuse       Date:  2022-05-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.